Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Price:
11.95
USD
-0.58%
Market Closed
Market Cap:
$850.1m
Balance Sheet
Balance Sheet Decomposition
Phathom Pharmaceuticals Inc
Phathom Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Phathom Pharmaceuticals Inc
Phathom Pharmaceuticals Inc
Balance Sheet
Phathom Pharmaceuticals Inc
Phathom Pharmaceuticals Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1
|
244
|
288
|
183
|
155
|
381
|
297
|
|
| Cash Equivalents |
1
|
244
|
288
|
183
|
155
|
381
|
297
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
39
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
39
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
|
| Other Current Assets |
0
|
12
|
4
|
3
|
5
|
13
|
21
|
|
| Total Current Assets |
1
|
256
|
291
|
187
|
161
|
397
|
360
|
|
| PP&E Net |
0
|
1
|
3
|
3
|
4
|
4
|
2
|
|
| PP&E Gross |
0
|
1
|
3
|
3
|
4
|
4
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
2
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
13
|
16
|
|
| Total Assets |
1
N/A
|
257
+28 478%
|
295
+15%
|
189
-36%
|
165
-13%
|
414
+151%
|
378
-9%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
17
|
5
|
10
|
13
|
11
|
|
| Accrued Liabilities |
0
|
3
|
31
|
14
|
16
|
19
|
55
|
|
| Short-Term Debt |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
7
|
0
|
0
|
7
|
20
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
4
|
56
|
19
|
26
|
39
|
86
|
|
| Long-Term Debt |
0
|
23
|
40
|
90
|
205
|
438
|
535
|
|
| Other Liabilities |
0
|
3
|
6
|
9
|
9
|
10
|
12
|
|
| Total Liabilities |
2
N/A
|
29
+1 227%
|
101
+245%
|
117
+16%
|
240
+104%
|
487
+103%
|
632
+30%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
256
|
386
|
529
|
727
|
929
|
1 263
|
|
| Additional Paid In Capital |
0
|
484
|
580
|
602
|
652
|
856
|
1 009
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
228
N/A
|
194
-15%
|
72
-63%
|
75
N/A
|
73
+3%
|
254
-249%
|
|
| Total Liabilities & Equity |
1
N/A
|
257
+28 478%
|
295
+15%
|
189
-36%
|
165
-13%
|
414
+151%
|
378
-9%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
26
|
25
|
29
|
31
|
42
|
58
|
69
|
|
Switch to:
Switch to:
See Also
Discover More
